These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29183910)

  • 21. Health-related quality of life and quality of life in type 2 diabetes: relationships in a cross-sectional study.
    Sundaram M; Kavookjian J; Patrick JH
    Patient; 2009 Jun; 2(2):121-33. PubMed ID: 22273088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications.
    Alcubierre N; Rubinat E; Traveset A; Martinez-Alonso M; Hernandez M; Jurjo C; Mauricio D
    Health Qual Life Outcomes; 2014 Aug; 12():131. PubMed ID: 25138117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health-related quality of life and glycaemic control in patients with Type 2 diabetes mellitus in Singapore.
    Shim YT; Lee J; Toh MP; Tang WE; Ko Y
    Diabet Med; 2012 Aug; 29(8):e241-8. PubMed ID: 22507291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effectiveness of basal-bolus versus premix analog insulin on glycemic variability and patient-centered outcomes during insulin intensification in type 1 and type 2 diabetes: a randomized, controlled, crossover trial.
    Testa MA; Gill J; Su M; Turner RR; Blonde L; Simonson DC
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3504-14. PubMed ID: 22851487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
    Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
    Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of glycemic control and quality-of-life by insulin lispro therapy: Assessing benefits by ITR-QOL questionnaires.
    Ishii H; Anderson JH; Yamamura A; Takeuchi M; Ikeda I
    Diabetes Res Clin Pract; 2008 Aug; 81(2):169-78. PubMed ID: 18495289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape).
    Vora J; Cohen N; Evans M; Hockey A; Speight J; Whately-Smith C
    Diabetes Obes Metab; 2015 Dec; 17(12):1133-41. PubMed ID: 26085028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between improved glucose control and patient-reported outcomes after initiation of insulin pump therapy in patients with type 2 diabetes mellitus.
    Peyrot M; Rubin RR; Chen X; Frias JP
    Diabetes Technol Ther; 2011 Apr; 13(4):471-6. PubMed ID: 21355725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes.
    Speight J; Reaney MD; Barnard KD
    Diabet Med; 2009 Apr; 26(4):315-27. PubMed ID: 19388959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the impact of diabetes on quality of life: validation of the Chinese version of the 19-item Audit of Diabetes-Dependent Quality of Life for Taiwan.
    Wang HF; Bradley C; Chang TJ; Chuang LM; Yeh MC
    Int J Qual Health Care; 2017 Jun; 29(3):335-342. PubMed ID: 28371823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL.
    Bradley C; Todd C; Gorton T; Symonds E; Martin A; Plowright R
    Qual Life Res; 1999; 8(1-2):79-91. PubMed ID: 10457741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Greater fear of hypoglycaemia with premixed insulin than with basal-bolus insulin glargine and glulisine: patient-reported outcomes from a 60-week randomised study.
    Polonsky WH; Thompson S; Wei W; Riddle MC; Chaudhari S; Jackson J; Bruno AS
    Diabetes Obes Metab; 2014 Nov; 16(11):1121-7. PubMed ID: 24919603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Hypoglycemia on Health-Related Quality of Life among Type 2 Diabetes: A Cross-Sectional Study in Thailand.
    Pratipanawatr T; Satirapoj B; Ongphiphadhanakul B; Suwanwalaikorn S; Nitiyanant W
    J Diabetes Res; 2019; 2019():5903820. PubMed ID: 31772942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient-reported outcomes in adults with type 1 diabetes in global real-world clinical practice: The SAGE study.
    Wilmot EG; Close KL; Jurišić-Eržen D; Bruttomesso D; Ampudia-Blasco FJ; Bosnyak Z; Roborel de Climens A; Bigot G; Peters AL; Renard E; Berard L; Calliari LE; Seufert J
    Diabetes Obes Metab; 2021 Aug; 23(8):1892-1901. PubMed ID: 33914401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of fear of hypoglycemia with second-line use of insulin secretagogues or insulin and subsequent glycemic control in patients with type 2 diabetes: An analysis using data from the DISCOVER study.
    Wang JS; Chen H; Tang F; Sheu WH
    Int J Clin Pract; 2020 Jun; 74(6):e13485. PubMed ID: 32003099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
    Vexiau P; Mavros P; Krishnarajah G; Lyu R; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():16-24. PubMed ID: 18435670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and effectiveness of insulin analogues in Moroccan patients with type 2 diabetes: a sub-analysis of the A₁chieve study.
    Chraibi A; Ajdi F; Belkhadir J; El Ansari N; Marouan F; Farouqi A
    Diabetes Res Clin Pract; 2013 Aug; 101 Suppl 1():S27-36. PubMed ID: 23958569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-reported outcomes after 10-year follow-up of intensive, multifactorial treatment in individuals with screen-detected type 2 diabetes: the ADDITION-Europe trial.
    Dalsgaard EM; Sandbaek A; Griffin SJ; Rutten GEHM; Khunti K; Davies MJ; Irving GJ; Vos RC; Webb DR; Wareham NJ; Witte DR
    Diabet Med; 2020 Sep; 37(9):1509-1518. PubMed ID: 32530523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examining the Behaviour subscale of the Hypoglycaemia Fear Survey: an international study.
    Gonder-Frederick LA; Vajda KA; Schmidt KM; Cox DJ; Devries JH; Erol O; Kanc K; Schächinger H; Snoek FJ
    Diabet Med; 2013 May; 30(5):603-9. PubMed ID: 23324032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality-of-life and treatment satisfaction in actual clinical practice of patients with Type 1 diabetes mellitus (T1DM) and hypoglycemia treated with insulin degludec.
    Lecumberri E; Ortega M; Iturregui M; Quesada JA; Vázquez C; Orozco D
    Curr Med Res Opin; 2018 Jun; 34(6):1053-1059. PubMed ID: 29300101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.